
AIkido Pharma AIKI
Geschäftsbericht 2025
hinzugefügt 31.03.2026
AIkido Pharma DPO 2011-2026 | AIKI
DPO Jährlich AIkido Pharma
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.92 | 7.63 | - | - | - | - | - | - | - | - | - | - | 32.8 K | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 32.8 K | 1.92 | 11 K |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Amphastar Pharmaceuticals
AMPH
|
31.7 | $ 21.77 | 1.68 % | $ 1.02 B | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
405 | $ 0.92 | 3.05 % | $ 6.76 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
75.2 | $ 22.44 | 2.16 % | $ 3.72 B | ||
|
Esperion Therapeutics
ESPR
|
7.93 K | $ 2.02 | 5.76 % | $ 420 M | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Heron Therapeutics
HRTX
|
91.4 | $ 1.26 | 6.3 % | $ 210 M | ||
|
ImmuCell Corporation
ICCC
|
19.5 | $ 8.28 | -0.84 % | $ 74.7 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Aquestive Therapeutics
AQST
|
395 | $ 4.14 | 1.47 % | $ 443 M | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 23.57 | 1.33 % | $ 3 B | ||
|
Jaguar Health
JAGX
|
676 | $ 0.36 | -8.39 % | $ 840 K | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.46 | 1.04 % | $ 389 M | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B | ||
|
KalVista Pharmaceuticals
KALV
|
1.03 K | $ 20.08 | 2.29 % | $ 1.08 B | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B |